King Makes Bid to Alpharma Shareholders
September 12, 2008 by Joseph McCafferty
Alpharma has repeatedly turned down King Pharmaceutical’s unsolicited bid. As promised, King is taking its proposal directly to Alpharma shareholders.
September 12, 2008 by Joseph McCafferty
Alpharma has repeatedly turned down King Pharmaceutical’s unsolicited bid. As promised, King is taking its proposal directly to Alpharma shareholders.
Tech Still Tough for Private Equity
April 7, 2008 by Joseph McCafferty
Freescale Semiconductor, once a signpost of the limitless bounds of private equity, is now a case study on why techonology firms can make poor buyout targets.
April 7, 2008 by Joseph McCafferty
Freescale Semiconductor, once a signpost of the limitless bounds of private equity, is now a case study on why techonology firms can make poor buyout targets.
Blackstone Concerned over Large Buyouts
November 13, 2007 by Joseph McCafferty
Blackstone Group Chairman and CEO Stephen Schwarzman has said that it has become hard to structure the largest leveraged transactions as the company made a net loss of $113 million for the third quarter.
November 13, 2007 by Joseph McCafferty
Blackstone Group Chairman and CEO Stephen Schwarzman has said that it has become hard to structure the largest leveraged transactions as the company made a net loss of $113 million for the third quarter.